E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/23/2019 in the Prospect News Distressed Debt Daily.

Insys Therapeutics asset sale bid deadline extended through July 26

By Caroline Salls

Pittsburgh, July 23 – Insys Therapeutics, Inc. has extended the deadline for all interested parties to bid on its assets through 4 p.m. ET on July 26, according to a notice filed Monday with the U.S. Bankruptcy Court for the District of Delaware.

The original bid deadline was 4 p.m. ET on July 23.

The company said the auction will take place as scheduled on Aug. 5.

The specialty pharmaceutical company is based in Phoenix. The company filed bankruptcy on June 10 under Chapter 11 case number 19-11292.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.